Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID

Haematologica

Volumn 95, Issue 10, 2010, Pages 1778-1782

  Cancrini, Caterina ^a   Ferrua, Francesca ^b,c   Scarselli, Alessia ^a   Brigida, Immacolata ^a,c   Romiti, Maria Luisa ^a   Barera, Graziano ^d   Finocchi, Andrea ^a   Roncarolo, Maria Grazia ^b,c   Caniglia, Maurizio ^e   Aiuti, Alessandro ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Bone marrow transplantation; Primary immunodeficiency; Reduced intensity conditioning

Indexed keywords

BUSULFAN; FLUDARABINE; T LYMPHOCYTE RECEPTOR;

ADENOSINE DEAMINASE DEFICIENCY; ADENOSINE DEAMINASE SEVERE COMBINED IMMUNODEFICIENCY; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CASE REPORT; CHIMERA; CONTROLLED STUDY; DONOR; ENZYME REPLACEMENT; GENE MUTATION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INFANT; NEUTROPENIA; REDUCED INTENSITY CONDITIONING; SEVERE COMBINED IMMUNODEFICIENCY; SIBLING; T LYMPHOCYTE;

ADENOSINE DEAMINASE; AGAMMAGLOBULINEMIA; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; INFANT; SEVERE COMBINED IMMUNODEFICIENCY; SIBLINGS; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, ISOGENEIC;

EID: 77957790346     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.025098     Document Type: Article

References (24)

1. Aiuti A, Brigida I, Ferrua F, Cappelli B, Chiesa R, Marktel S, et al. Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID. Immunol Res. 2009;44(1-3):150-159.
2. Hershfield MS. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy. Semin Hematol. 1998;35(4): 291-298.
3. Hirschhorn R, Candotti F. Immuno deficiency Due to Defects of Purine Metabolism. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach, Second Edition Oxford University Press. 2006; Chapter 12:169-196.
4. Gaspar HB, Aiuti A, Porta F, Candotti F, Hershfield MS, Notarangelo LD. How I treat ADA deficiency. Blood. 2009;114(17): 3524-3532.
5. Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 2009;360(5):447-458.
6. Gaspar HB, Bjorkegren E, Parsley K, Gilmour KC, King D, Sinclair J, et al. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol Ther. 2006; 14(4):505-513.
7. Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009;113(17):4114-4124.
8. Cavazzana-Calvo M, Carlier F, Le Deist F, Morillon E, Taupin P, Gautier D, et al. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary Tcell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood. 2007;109(10):4575-4581.
9. Dvorak CC, Cowan MJ. Hematopoietic stem cell transplantation for primary immunodeficiency disease. Bone Marrow Transplant. 2008;41(2):119-126.
10. Haddad E, Le Deist F, Aucouturier P, Cavazzana-Calvo M, Blanche S, De Saint Basile G, et al. Long-term chimerism and Bcell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A singlecenter study of 22 patients. Blood. 1999; 94(8):2923-2930.
11. Sauer AV, Mrak E, Hernandez RJ, Zacchi E, Cavani F, Casiraghi M, et al. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. Blood. 2009;114 (15):3216-3226.
12. Honig M, Albert MH, Schulz A, Sparber-Sauer M, Schutz C, Belohradsky B, et al. Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. Blood. 2007;109(8):3595-3602.
13. Rogers MH, Lwin R, Fairbanks L, Gerritsen B, Gaspar HB. Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency. J Pediatr. 2001;139(1):44-50.
14. Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, et al. Correction of ADASCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science. 2002;296(5577):2410-2413.
15. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conven-tional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998;91(3):756-763.
16. Straathof KC, Rao K, Eyrich M, Hale G, Bird P, Berrie E, et al. Haemopoietic stemcell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study. Lancet. 2009;374(9693):912-920.
17. Veys P. Reduced intensity transplantation for primary immunodeficiency disorders. Immunol Allergy Clin North Am. 2010; 30(1):103-124.
18. Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr. 1997;130(3):388-393.
19. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112(5): 973-980.
20. Finocchi A, Romiti ML, Di Cesare S, Puliafito P, Pensieroso S, Rana I, et al. Rapid T-cell receptor CD4+ repertoire reconstitution and immune recovery in unrelated umbilical cord blood transplanted pediatric leukemia patients. J Pediatr Hematol Oncol. 2006;28(7):403-411.
21. Patel NC, Chinen J, Rosenblatt HM, Hanson IC, Krance RA, Paul ME, et al., Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with or without preconditioning. J Allergy Clin Immunol 2009;124(5):1062-1069.
22. Mackall CL, Stein D, Fleisher TA, Brown MR, Hakim FT, Bare CV, et al. Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood. 2000; 96(2):754-762.
23. Sarzotti M, Patel DD, Li X, Ozaki DA, Cao S, Langdon S, et al. T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation. J Immunol. 2003;170(5):2711-2718.
24. Wu CJ, Chillemi A, Alyea EP, Orsini E, Neuberg D, Soiffer RJ, et al. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to he matopoietic chimerism. Blood. 2000; 95(1):352-359.